In the past 5 years, health care cost containment strategies have proliferated at an unprecedented rate in an effort to limit health care's gross domestic product footprint.1 The Medicare Authorization and CHIP Reauthorization Act (MACRA), which repealed the Sustainable Growth Rate Formula, includes far-reaching provisions to improve health care quality and value. For facial plastic surgery, these changes underscore the need to measure the value of facial reconstruction. Advances in facial plastic surgery optimize tissue perfusion in facial reconstruction2,3 and allow cost-based decision analysis for fracture management.4 But, how can we quantify the value of restoring a face?
Brenner MJ. What Cost-Utility Analysis Can Teach Us About Facial Deformity: Gambles, Trade-offs, and Willingness to Pay. JAMA Facial Plast Surg. 2016;18(4):249–250. doi:10.1001/jamafacial.2016.0044
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: